Epigraph:
Every human life is precious and sacred and saving one is like saving the whole of humanity. (Al Quran 5:32/33)
Pfizer’s Covid Vaccine Prevents 90% of Infections in Study
By Robert Langreth, Naomi Kresge, and Riley Griffin
Source: Bloomberg
- Preliminary results could pave way for vaccine by year-end
- Pfizer, BioNTech expect to get two-month safety data next week
The Covid-19 vaccine being developed by Pfizer Inc. and BioNTech SE prevented more than 90% of infections in a study of tens of thousands of volunteers, the most encouraging scientific advance so far in the battle against the coronavirus.
Eight months into the worst pandemic in a century, the preliminary results pave the way for the companies to seek an emergency-use authorization from regulators if further research shows the shot is also safe.
Suggested Reading by Zia H Shah MD, Chief Editor of the Muslim Times:
We are thankful to the scientists that have contributed to this discovery now and in previous generations, Pfizer company and others involved in this progress and last but not the least, volunteers who tried the vaccine for the benefit of humanity.
Praise be to God for the Miracle of Our Immune System
Thirty Plus Quotes from the Poet of Love
Two Hundred Verses about Compassionate Living in the Quran
A Message of Compassion and Love from the Holy Bible
True Fasting: A Message of Compassion and Love from the Old Testament
Abou Ben Adhem, A Compassionate Man
‘Love Hormone,’ How it works in Hospitality?
‘Love Hormone’ Oxytocin May Enhance Feelings Of Spirituality
I am a Jew, a Catholic, a Christian and a Muslim; I am Zia H Shah
(CNN) Drugmaker Pfizer said Monday an early look at data from its coronavirus vaccine shows it is more than 90% effective — a much better than expected efficacy if the trend continues.
The so-called interim analysis looked at the first 94 confirmed cases of Covid-19 among the more than 43,000 volunteers who got either two doses of the vaccine or a placebo. It found that fewer than 10% of infections were in participants who had been given the vaccine. More than 90% of the cases were in people who had been given a placebo.
Pfizer said that the vaccine provided protection seven days after the second dose and 28 days after the initial dose of the vaccine. The final goal of the trial is to reach 164 confirmed cases of coronavirus infection.
In a news release, the pharmaceutical giant said it plans to seek emergency use authorization from the US Food and Drug Administration soon after volunteers have been monitored for two months after getting their second dose of vaccine, as requested by the FDA.
https://www.cnn.com/2020/11/09/health/pfizer-covid-19-vaccine-effective/index.html
(CNN)Brazil’s health regulator has suspended trials of a Chinese-developed Covid-19 vaccine following a “serious adverse event” involving a volunteer recipient, according to sources cited by CNN’s affiliate, CNN Brasil.
Chinese drugmaker Sinovac Biotech began Phase 3 trials of its CoronaVac in collaboration with the Brazilian Butantan Institute in Sao Paulo in late July, with an aim to recruit 130,000 volunteers. Phase 3 trials represent the final and most important testing stage before regulatory approval is sought.
The pause in testing marks a potential setback for one of China’s leading vaccine candidates and comes as US drugmaker Pfizer said Monday that early data from its own coronavirus vaccine showed more than 90% effectiveness.
According to a note from Brazil’s National Health Surveillance Agency, an incident reported on October 29 led to a decision to suspend the trial in order to better evaluate the data and assess the risk.
https://www.cnn.com/2020/11/10/health/brazil-suspends-china-vaccine-trials-intl-hnk/index.html